The Pregnancy and Family Care Act aims to improve support and treatment for pregnant patients with substance use disorders and their families. It mandates that healthcare providers screen pregnant patients for substance use disorders during their initial healthcare visit, with the option for follow-up screenings throughout treatment. Providers are also required to create family care plans for those diagnosed with substance use disorders, ensuring a holistic approach to their health and social needs. The act establishes a notification system for reporting the birth of substance-exposed infants to the Department of Health, while clarifying that such reports will not automatically initiate child abuse investigations. Additionally, the act creates statewide and county perinatal advisory councils to offer recommendations and address issues related to perinatal substance use disorders.

The bill further enhances the coordinated response of state agencies to perinatal substance use disorder by focusing on racial and ethnic disparities in treatment access, the distribution of educational materials, and improved communication with policymakers. It emphasizes collaboration with the statewide perinatal advisory council and the allocation of resources to underserved areas. A notable addition is the requirement for the Department of Health to provide an annual report starting November 1, 2026, to legislative committees and the governor, detailing information and recommendations on perinatal substance use disorder. The bill also repeals two previous sections of the law to streamline the legal framework surrounding these initiatives.